START Midwest

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

START Midwest

Aug 3, 2024, 06:55 | Blog

START Midwest team has dosed the first patient in the Loxo Lilly study - The START Center for Cancer Research

The START Center for Cancer Research shared a post on Linkedin: "We are thrilled to…

Jul 1, 2024, 11:57 | Insight

START Midwest team has successfully dosed the first patient in the first QTX3046 Phase I trial

The START Center for Cancer Research shared on LinkedIn: "We are proud to announce that…

Jun 23, 2024, 13:45 | Insight

START Midwest team has successfully dosed all three patients in the first cohort of the LOXO-FRA-24001 (J5E-OX-JZXA) trial

The START Center for Cancer Research shared on LinkedIn: . "We…

All: 3 Posts: 1 - 100

'

In Memory of Bob Marley: His Battle with Melanoma and the Importance of Early Detection

'

Who From Oncology is Featured in TIME100 Health 2025?

'

FDA Announces Aggressive Timeline to Scale 1st AI-Assisted Scientific Review Pilot

'

The Evolving Therapeutic Revolution in Adult Acute Lymphoblastic Leukemia

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023